Amedisys board of directors authorizes $100 million stock repurchase program

Baton rouge, la., feb. 09, 2023 (globe newswire) -- amedisys, inc. (nasdaq: amed), a leading provider of quality home health, hospice, personal care and high-acuity care, today announced that its board of directors has authorized a stock repurchase program, under which the company may repurchase up to $100 million of its outstanding common stock through december 31, 2023.

AMED Ratings Summary

AMED Quant Ranking